1
|
García-Campayo J, Zamorano E, Ruíz M, Pardo A, Freire O, Pérez-Páramo M, López-Gómez V, Rejas J. Cultural Adaptation into Spanish of the Generalized Anxiety Disorder Scale - 7 (GAD-7) Scale. Eur Psychiatry 2020. [DOI: 10.1016/s0924-9338(09)70771-0] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/21/2022] Open
Abstract
Purpose:To carry out cultural adaptation and validation into Spanish of the 7-items self-administered GAD-7 scale; a tool to identify probable patients with Generalized Anxiety Disorder (GAD).Material and methods:The adaptation, conducted by an eight-expert panel, was performed by means of a conceptual equivalence process, including forward and backward translations in duplicate to the original language. The content validity was assessed by inter-ratter-agreement (item-goal congruence index of Rovinelli-Hambleton). The adapted version was administered to patients with GAD according to DSM IV criteria and their respective controls, matched by age and sex, who were recruited at random in Mental Health and Primary Care centres to verify scale feasibility and potential understanding problems.Results:The inter-ratter reliability confirmed the correct inclusion of items in the corresponding dimension of GAD. The study sample consisted of 8 patients with GAD and 8 controls (62.5% male), mean age 50.38 years (SD=16.76). The average time to completion was 2’30”. No items of the scale were left blank. Floor and ceiling effects were negligible. No patients with GAD had to be assisted to fill in the questionnaire. All the items, except item 5 (p=0,105), showed statistically significant differences among groups (p< 0.05).Conclusion:After the adaptation process, a Spanish version of the GAD-7 scale was obtained, confirming its content validity, pertinence and adequacy of items in the Spanish cultural context. The brief time to completion precluded a fast and easy self-administration in the routine medical practice to promptly detect probable cases of GAD.
Collapse
|
2
|
Bobes J, Rubio G, Terán A, Cervera G, López-Gómez V, Vilardaga I, Pérez M. Pregabalin for the discontinuation of long-term benzodiazepines use: An assessment of its effectiveness in daily clinical practice. Eur Psychiatry 2020; 27:301-7. [DOI: 10.1016/j.eurpsy.2010.12.004] [Citation(s) in RCA: 34] [Impact Index Per Article: 8.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/07/2010] [Revised: 12/15/2010] [Accepted: 12/17/2010] [Indexed: 11/24/2022] Open
Abstract
AbstractPurposeTo evaluate the effectiveness and tolerability of pregabalin in the management of the discontinuation of benzodiazepines in long-term users.Subjects and methodsWe performed a 12-week, prospective, uncontrolled, non-interventional, and observational study in patients aged 18 years old or above, who met DSM-IV-TR criteria for benzodiazepine dependence without other major psychiatry disorder. Evaluations included the Benzodiazepine Withdrawal Symptom Questionnaire, the Hamilton Anxiety Rating Scale, the Clinical Global Impression Scale, and the Sheehan Disability Scale. A urine drug screen for benzodiazepines was performed at baseline and every 4 weeks thereafter. The primary effectiveness variable was success rate, defined as achievement of benzodiazepine-free status at week 12 according to the urine drug screen.Results and discussionThe mean dose at week 12 was 315 (±166) mg/day. The success rate of the benzodiazepine taper in the primary efficacy population (n = 282) was 52% (95% confidence interval [CI], 46–58). Success rates for women and men were 58% (95% CI, 49–67) and 46% (95% CI, 38–55), respectively. The success rates did not differ according to either the benzodiazepine of abuse or the presence of other substance use disorders. Significant and clinically relevant improvements were observed in withdrawal and anxiety symptoms, as well as in patients’ functioning. At week 12, tolerability was rated as good or excellent by 90% and 83% of the clinicians and patients, respectively.ConclusionOur results suggest that pregabalin is an efficacious and well-tolerated adjunctive treatment for benzodiazepine withdrawal.
Collapse
|
3
|
Domínguez-Comesaña E, Domínguez-Fernández R, Quiroga-Veiga N, López-Gómez V, Estévez-Fernández S. Are reactive C protein and procalcitonin useful for early diagnosis of postoperative intraabdominal infection after pancreaticoduodenectomy for pancreatic cancer? CIR CIR 2019; 87:662-666. [PMID: 31631192 DOI: 10.24875/ciru.19000855] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
Objective To evaluate the relationship between C reactive protein and procalcitonin levels and the appearance of post-operative intraabdominal infection, in patients with pancreaticoduodenectomy due to pancreatic cancer. Method A prospective observational study, including 35 patients, was made. Procalcitonin and C reactive protein were measured before surgery, as well as 24, 48 and 72 h after the surgical procedure. Patients were divided in two groups, with and without intraabdominal infection. Results Six patients (17.1%) presented post-operative intraabdominal infection. Both, procalcitonin and C reactive protein, increased in all patients after surgery, but there were no significant differences between the two groups. However, the ratio between the C reactive protein concentrations on post-operative day 3 and the concentrations on post-operative day 1 was significantly increased in the group of patients with intraabdominal infection. The predictive positive value and the predictive negative value for this ratio were 60% and 95%, respectively, for a cut-off point of 2.3. Conclusions The ratio between C reactive protein value on post-operative day 3 and the value on post-operative day 1 is a good predictor of post-operative intraabdominal infection after pancreaticoduodenectomy.
Collapse
Affiliation(s)
| | | | | | - Victoria López-Gómez
- Servicio de Análisis Clínicos. Complejo Hospitalario de Pontevedra, Pontevedra, España
| | | |
Collapse
|
4
|
López-Gómez V, Yarza R, Muñoz-González H, Revilla E, Enrech S, González-Valle O, Tolosa P, Ciruelos E. Ribociclib-Related Stevens-Johnson Syndrome: Oncologic Awareness, Case Report, and Literature Review. J Breast Cancer 2019; 22:661-666. [PMID: 31897340 PMCID: PMC6933037 DOI: 10.4048/jbc.2019.22.e44] [Citation(s) in RCA: 15] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/14/2019] [Accepted: 08/12/2019] [Indexed: 12/19/2022] Open
Abstract
Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis belong to a severe dermatopathic spectrum that includes frequently fatal mucocutaneous manifestations consisting of whole epidermal necrosis and sloughing with bullous transformation, blistering, and further skin detachment. Notably, cancer patients are at higher risk of developing SJS than the general population as a consequence of both the nature of neoplastic disease and frequent exposure to anticancer drugs. Ribociclib is a newly approved cycline-dependent kinase inhibitor that has been recently associated with a single case of SJS. We hereby present a case of ribociclib-related SJS. Early detection of threatening skin lesions is crucial to permit the immediate discontinuation of ribociclib given the predictable and unacceptable risk level. In cases of established SJS, early aggressive support should be initiated, ribociclib should be abruptly discontinued, and specific treatment based on actual evidence should be started.
Collapse
Affiliation(s)
- Victoria López-Gómez
- Department of Clinical Oncology, University Hospital 12 de Octubre, Madrid, Spain
| | - Ramón Yarza
- Department of Clinical Oncology, University Hospital 12 de Octubre, Madrid, Spain
| | | | - Enrique Revilla
- Department of Pathology, University Hospital 12 de Octubre, Madrid, Spain
| | - Santos Enrech
- Department of Clinical Oncology, Getafe Hospital, Madrid, Spain
| | | | - Pablo Tolosa
- Department of Clinical Oncology, University Hospital 12 de Octubre, Madrid, Spain.,Division of Gyneco-Oncology, Breast Cancer Unit, University Hospital 12 de Octubre, Madrid, Spain
| | - Eva Ciruelos
- Department of Clinical Oncology, University Hospital 12 de Octubre, Madrid, Spain.,Division of Gyneco-Oncology, Breast Cancer Unit, University Hospital 12 de Octubre, Madrid, Spain
| |
Collapse
|
5
|
Domínguez-Comesaña E, López-Gómez V, Estevez-Fernández SM, Mariño Padín E, Ballinas-Miranda J, Carrera-Dacosta E, Piñon-Cimadevila MÁ, Barreiro-Morandeira F. [Procalcitonin and C-reactive protein as early indicators of postoperative intra-abdominal infection after surgery for gastrointestinal cancer]. Cir Esp 2014; 92:240-6. [PMID: 24445075 DOI: 10.1016/j.ciresp.2013.09.015] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/10/2013] [Revised: 09/25/2013] [Accepted: 09/26/2013] [Indexed: 12/12/2022]
Abstract
AIM to evaluate the association between serum levels of procalcitonin and C-reactive protein, on the first 3 postoperative days, and the appearance of postoperative intra-abdominal infection. METHOD Prospective observational study including 67 patients operated on for colo-rectal, gastric and pancreatic cancer. Serum levels of procalcitonin and C-reactive protein were analyzed before surgery and daily until the third postoperative day. Values of procalcitonin (PCT) and C-reactive protein (CRP) were recorded as well as their accuracy for detection of postoperative intra-abdominal infection (PIAI). RESULTS The incidence of postoperative intra-abdominal infection was 13.4%. CRP serum levels at 72h, PCT serum levels at 24, 48 and 72h and the ratio between serum levels of CRP at 72hours and serum levels of CRP at 48hours (CRP D3/CRP D2) were significantly associated with the appearance of postoperative intra-abdominal infection. The highest sensitivity corresponded to PCT at 72hours (88.9%); the highest specificity and positive predictive value corresponded to the ratio CRP D3/CRP D2 (96.49% and 71.4%, respectively); the highest negative predictive value to procalcitonin at 72h and 24h. CONCLUSIONS Serum levels of PCT are significantly associated with the appearance of postoperative intra-abdominal infection. Sensitivity and predictive positive values are low, but negative predictive value is high, even at 24h after surgery.
Collapse
Affiliation(s)
| | - Victoria López-Gómez
- Servicio de Análisis Clínicos, Complejo Hospitalario de Pontevedra, Pontevedra, España
| | | | - Esther Mariño Padín
- Servicio de Cirugía, Complejo Hospitalario de Pontevedra, Pontevedra, España
| | | | | | | | | |
Collapse
|
6
|
Olivares J, Carrasco J, Alvarez E, Perez M, López-Gómez V, Rejas J. P-147 - A comparative cost-analysis of initiating pregabalin or SSRI/SNRI therapy in benzodiazepine resistant patients with generalized anxiety disorder. Eur Psychiatry 2012. [DOI: 10.1016/s0924-9338(12)74314-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
|
7
|
Alvarez E, Carrasco J, Olivares J, López-Gómez V, Perez M, Rejas J. P-148 - Utilization of concomitant anxiolytic treatment in benzodiazepine-resistant patients initiating pregabalin or SSRI/SNRI for the treatment of generalized anxiety disorder (GAD). Eur Psychiatry 2012. [DOI: 10.1016/s0924-9338(12)74315-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/26/2022] Open
|
8
|
Affiliation(s)
- Victoria López-Gómez
- Laboratorio de Análisis Clínicos, Complejo Hospitalario de Pontevedra, Pontevedra, Spain
| | - Isabel González-García
- Laboratorio de Análisis Clínicos, Complejo Hospitalario de Pontevedra, Pontevedra, Spain
| | - Teresa Aparicio-Casans
- Laboratorio de Análisis Clínicos, Complejo Hospitalario de Pontevedra, Pontevedra, Spain
| | | |
Collapse
|
9
|
Olivares J, Carrasco J, Alvarez E, Pérez M, López-Gómez V, Vilardaga I, Rejas J. Effect of pregabalin on generalized anxiety disorder patients with severe symptoms of anxiety and depression refractory to duloxetin. Eur Psychiatry 2011. [DOI: 10.1016/s0924-9338(11)71884-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/30/2022] Open
Abstract
PurposeThe purpose of this research was to analyse the effect of adding Pregabalin (PGB) on severe symptoms of anxiety and depression in patients with Generalized Anxiety Disorder refractory to duloxetin in daily medical practice in Spain.MethodsThis is a post-hoc analysis of a 6-month multicentre, prospective and observational study carried out in outpatient psychiatric clinics in Spain. Men and women, above 18 years, with a diagnosis of GAD according with DSM-IV-TR criteria, pregabalin naïve and refractory to a previous course of duloxetin (3 months or more) and severe symptoms of anxiety (HAM-A ≥ 24) and depression (MADRS ≥ 35) were considered eligible for analysis.ResultsA total of twenty-five patients [76% women, mean age; 49.3 (11.8) years, 82% with a comorbid depressive disorder] fulfilled criteria for analysis, and were previously exposed to duloxetin [mean dose: 71.7 (26.7) mg/day] for an average of 6.7 (3.7) months. Adding pregabalin [mean dose: 172.8 (75.5) mg/day], during 5.2 (1.8) months, reduced both anxiety and depressive symptoms by a mean of, respectively in HAM-A and MADRS scales, 54.1% (from 36.5 ± 4.3 pts to 16.6 ± 9.1 pts; p < 0.001, effect size: 4.63) and 52.8% (from 40.4 ± 4.6 pts to 19.0 ± 11.0 pts; p < 0.001, effect size: 4.65). As a result, the percentages of patients without symptoms of either anxiety or depression were 30% and 24%, respectively.ConclusionDespite small sample, adding pregabalin had a meaningful and significant effect on severe symptoms of anxiety and depressive symptoms in patients with severe GAD and concomitant depressive disorder resistant to duloxetin.
Collapse
|
10
|
Alvarez E, Carrasco J, Olivares J, Pérez M, López-Gómez V, Vilardaga I, Rejas J. Broadening diagnostic criteria of generalized anxiety disorders from DSM-IV: The impact on patient level of disability. Eur Psychiatry 2011. [DOI: 10.1016/s0924-9338(11)71883-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
Abstract
PurposeTo explore the consequences of broadening DSM-IV criteria for Generalized Anxiety Disorder (GAD) on patient's disability.MethodsA multicentre and observational study was carried-out in outpatient psychiatric clinics in Spain between years 2007 and 2008. Naïve diagnosed patients with GAD according to DSM-IV criteria or with anxiety symptoms fulfilling broadened criteria were compared. At least 1-month of excessive or non-excessive worry along with only two of the associated symptoms listed on DSM-IV for GAD were considered as broadened GAD criteria. Socio-demographic data, medical history and functional outcome measures were recorded.ResultsA total of 3,549 patients were systematically recruited, 12.8% excluded because not found eligible for inclusion in analysis; 1,815 in the DSM-IV group (DG) and 1,264 in the broadening criteria group (BG). Both groups were similar on their sociodemographic characteristics. Total disability score in the WHO-DAS II scale was slightly, but statistically significant, higher in DG; 41.9 (17.1) versus 38.9 (16.0) points, p < 0.05. These weak differences were observed in all of the scale domains but mainly in domains “Getting around” [34.5 (23.6) versus 29.4 (22.8), p< 0.05] and “Life activities” [55.5 (27.1) versus 52.1 (26.2), p< 0.05], since differences in the other domains, even statistically significant, were negligible.ConclusionPatients with standard DSM-IV criteria for GAD appears to show slightly, but significant, worst level of disability than subjects with broadening diagnostic GAD criteria. Life-activities and participation in society domains seems to be the functional domains most impacted by symptoms of anxiety.
Collapse
|
11
|
Olivares J, Carrasco J, Álvarez E, Perez M, López-Gómez V, Vilardaga I, Rejas J. P01-153 - Effect of Pregabalin on patients with refractory-severe generalized anxiety disorder and concomitant severe symptoms of depression in daily medical practice. Eur Psychiatry 2010. [DOI: 10.1016/s0924-9338(10)70358-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/26/2022] Open
|
12
|
Rubio G, Bobes J, Cervera G, Terán A, Perez M, López-Gómez V, Rejas J. PW01-241 - The effect of pregabalin on subjective sleep problems during withdrawal from long-term benzodiazepine use. Eur Psychiatry 2010. [DOI: 10.1016/s0924-9338(10)71648-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
|
13
|
Carrasco J, Álvarez E, Olivares J, Perez M, López-Gómez V, de Salas M, Rejas J. PW01-51 - The effect of broadening generalized anxiety disorders definition on healthcare resources utilization and costs: a corollary from the adan study. Eur Psychiatry 2010. [DOI: 10.1016/s0924-9338(10)71453-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/19/2022] Open
|